Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/26/25 16:47 | 3/24/25 | TARS | Health | BioPrd | Biological Products, (No Diag | Azamian Bobak R. | CA | DO | P,CEO,Bo | 3 | S.dm | -1,463 | 17.93 | 0 | -82 | 908 | I | |||||||||||||||
3/20/25 21:49 | 3/18/25 | TARS | Health | BioPrd | Biological Products, (No Diag | Mottiwala Aziz | CA | O | Chief Co | 2 | S.dm | -506 | 16.05 | 0 | -32 | 76 | D | |||||||||||||||
3/20/25 21:49 | 3/18/25 | TARS | Health | BioPrd | Biological Products, (No Diag | Neervannan Seshadri | CA | O | COO | 2 | S.dm | -363 | 12.59 | 0 | -29 | 87 | D | |||||||||||||||
3/20/25 21:49 | 3/18/25 | TARS | Health | BioPrd | Biological Products, (No Diag | Wahl Bryan | CA | O | GC | 2 | S.dm | -464 | 16.05 | 0 | -29 | 61 | D | |||||||||||||||
3/20/25 21:48 | 3/18/25 | TARS | Health | BioPrd | Biological Products, (No Diag | Whitfield Dianne C. | CA | O | CHRO | 2 | S.dm | -321 | 12.55 | 0 | -26 | 53 | D | |||||||||||||||
3/20/25 21:48 | 3/18/25 | TARS | Health | BioPrd | Biological Products, (No Diag | Farrow Jeffrey S | CA | O | See Rema | 2 | S.dm | -178 | 15.18 | 0 | -12 | 26 | D | |||||||||||||||
3/11/25 16:01 | 3/7/25 | TARS | Health | BioPrd | Biological Products, (No Diag | Goldberg Andrew D. | CA | D | 1 | M.d | 90 | 12.89 | 0 | 7 | 110 | 13 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |